Sexually Transmitted Diseases

>

Latest News

Long-Acting Injectables for the Prevention or Treatment of HIV
Long-Acting Injectables for the Prevention or Treatment of HIV

October 1st 2024

In the third installment of our series on injectables, long-acting injectables offer new treatment and prevention options for HIV, especially benefiting patients who struggle with daily oral medications.

WHO Prequalifies a Mpox Vaccine, Clearing Path to Access
WHO Prequalifies a Mpox Vaccine, Clearing Path to Access

September 15th 2024

Lenacapavir Reduces HIV Infections by 96%, Demonstrates Superiority Over Another HIV Prophylactic
Lenacapavir Reduces HIV Infections by 96%, Demonstrates Superiority Over Another HIV Prophylactic

September 12th 2024

HIV Roundtable: Aging with HIV, Multidrug Resistance, and Vaccine Development
HIV Roundtable: Aging with HIV, Multidrug Resistance, and Vaccine Development

August 28th 2024

Video Series
Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.